List of insiders holdings for WINDTREE THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | LPH Investments Ltd 10% Owner |
2019-12-20 13:07:49 | 16,386,200 0 |
16,386,200 | Form 13D |
2 | Lee's Pharmaceutical Holdings Ltd 10% Owner |
2019-12-10 19:54:04 | 0 15,278,414 |
15,278,414 | Form 4 |
3 | China Cardiovascular Focus Ltd Lee's Pharmaceutical International Ltd 10% Owner |
2018-12-31 15:55:54 | 8,063,861 0 |
8,063,861 | Form 13D |
4 | Panacea Venture Healthcare Fund I L.P. 10% Owner |
2018-12-31 16:45:24 | 6,791,018 0 |
6,791,018 | Form 13D |
5 | Center Laboratories Inc. 10% Owner |
2022-01-10 17:03:57 | 1,239,088 5,095,014 |
6,334,102 | Form 4 |
6 | LPH II Investments Ltd 10% Owner |
2019-12-20 13:05:01 | 5,876,935 0 |
5,876,935 | Form 13D |
7 | Ivy Blue Holdings Ltd KPCB China Fund II L.P. KPCB China Associates II L.P. KPCB China Holdings II Ltd. 10% Owner |
2018-12-31 16:39:03 | 4,336,790 0 |
4,336,790 | Form 13D |
8 | Bioengine Capital Inc. 10% Owner |
2022-01-10 17:03:07 | 3,855,926 0 |
3,855,926 | Form 4 |
9 | CAPETOLA ROBERT J Former President/CEO |
2010-02-09 17:15:50 | 418,479 17,938 |
436,417 | Form 5 |
10 | SCHABER CHRISTOPHER Exec. VP & COO |
2006-01-05 16:43:24 | 287,771 0 |
287,771 | Form 4 |
11 | ESTEVE ANTONIO PHD Director |
2012-06-12 16:23:10 | 60,341 213,438 |
273,779 | Form 4 |
12 | COOPER JOHN G President & CEO |
2015-07-24 16:36:50 | 105,980 47,511 |
153,491 | Form 4 |
13 | Magee Michael L VP, Quality Operations |
2015-03-31 16:33:53 | 100,000 31,388 |
131,388 | Form 4 |
14 | Cole Kathy Senior VP, Human Resources |
2015-03-31 16:30:47 | 86,667 39,419 |
126,086 | Form 4 |
15 | NIVEN RALPH SVP-Preclinical Dev-Former |
2005-06-03 11:59:15 | 103,265 0 |
103,265 | Form 4 |
16 | Huang James Director |
2023-05-17 07:30:26 | 75,609 0 |
75,609 | Form 13D |
17 | Hamill John P. SVP & CFO |
2022-07-26 16:38:04 | 72,800 0 |
72,800 | Form 4 |
18 | Clayton Russell Senior VP, R&D |
2014-03-10 16:43:16 | 53,466 18,854 |
72,320 | Form 4 |
19 | LINK MAX Director |
2012-06-12 16:24:49 | 71,121 0 |
71,121 | Form 4 |
20 | Osterman Mark G SVP, Sales and Marketing |
2006-01-05 16:31:50 | 57,074 0 |
57,074 | Form 4 |
21 | Miller Thomas F SVP, Chief Operating Officer |
2015-02-17 17:07:08 | 15,460 39,540 |
55,000 | Form 5 |
22 | Amick W Thomas Chief Executive Officer |
2013-02-13 16:52:21 | 29,333 15,957 |
45,290 | Form 5 |
23 | Hoy Thomas VP, Manufacturing Ops. |
2015-02-17 16:57:42 | 6,667 36,212 |
42,879 | Form 5 |
24 | Curtis Eric SVP & COO |
2023-08-25 18:00:05 | 37,920 0 |
37,920 | Form 4 |
25 | ZODDA DENI M PHD Sr VP, Business Development |
2006-01-05 17:03:46 | 36,949 0 |
36,949 | Form 4 |
26 | MCDADE HERBERT H Director |
2010-12-22 14:58:16 | 30,000 0 |
30,000 | Form 4 |
27 | Loh Evan Director |
2021-02-05 21:01:23 | 30,000 0 |
30,000 | Form 4 |
28 | Katzer Charles F SVP, Manufacturing Operations |
2010-02-09 17:15:17 | 20,000 9,381 |
29,381 | Form 5 |
29 | McAndrew Jamie VP, Controller, & CAO |
2023-09-05 19:21:25 | 26,433 1 |
26,434 | Form 3 |
30 | LOPEZ DAVID L Executive VP & General Counsel |
2011-08-01 08:33:46 | 17,456 8,033 |
25,489 | Form 4 |
31 | PEACOCK BRUCE Director |
2021-02-05 21:14:43 | 23,886 0 |
23,886 | Form 4 |
32 | ROSENTHALE MARVIN E Director |
2016-08-08 16:08:09 | 21,211 1,666 |
22,877 | Form 4 |
33 | Leone John R Director |
2021-02-05 21:05:38 | 22,473 0 |
22,473 | Form 4 |
34 | Joseph Mahady M Director |
2021-02-05 21:08:04 | 22,455 0 |
22,455 | Form 4 |
35 | Schreiber Brian D Director |
2021-02-05 21:09:28 | 17,069 0 |
17,069 | Form 4 |
36 | SEGAL ROBERT-MD Senior VP, Sci & Med Affairs |
2011-02-09 14:31:27 | 8,635 3,930 |
12,565 | Form 5 |
37 | DAVIS CYNTHIA VP, Business Admin & Treasury |
2005-06-14 17:00:05 | 10,000 0 |
10,000 | Form 4 |
38 | Fraser Craig President and CEO |
2024-10-09 07:46:52 | 8,638 1 |
8,639 | Form 4 |
39 | Strobeck Mark Director |
2023-08-25 18:03:00 | 5,750 0 |
5,750 | Form 4 |
40 | Geffken Daniel E. Director |
2023-08-29 16:37:19 | 5,225 0 |
5,225 | Form 4 |
41 | SCOTT ROBERT A Director |
2023-08-25 18:01:54 | 5,183 0 |
5,183 | Form 4 |
42 | Williams Leslie J. Director |
2023-08-25 18:03:42 | 5,183 0 |
5,183 | Form 4 |
43 | Simonson Steven SVP, Chief Medical Officer |
2024-07-24 17:28:26 | 2,687 0 |
2,687 | Form 4 |
44 | Templeton Mary B Esq SVP, Gen Counsel & Corp Sec |
2020-05-27 21:56:57 | 2,237 332 |
2,569 | Form 4 |
45 | CARMAN DIANE SVP & General Counsel |
2023-03-02 20:25:02 | 1,227 0 |
1,227 | Form 4 |
46 | Tattory John A Interim CFO |
2023-02-03 16:05:09 | 0 0 |
0 | Form 3 |
47 | McGowan Kathleen A Director, Finance & Controller Director |
2008-01-08 15:09:13 | 0 0 |
0 | Form 4 |
48 | Latkin Jed Director |
2024-08-14 16:20:39 | 0 0 |
0 | Form 3 |
49 | PELLETIER SAUNDRA L Director |
2024-08-14 16:24:25 | 0 0 |
0 | Form 3 |
50 | Kelly Leanne Director |
2025-01-14 16:17:38 | 0 0 |
0 | Form 3 |